Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | 0 | reported | 18 Mar 2026 | tx 206+980,925−993,697 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 22,750 | 36.75 USD | |
| 16 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 4,250 | 29.61 USD | |
| 18 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 412 | 50.48 USD | |
| 16 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 18,000 | 32.20 USD | |
| 16 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 5,000 | 27.94 USD | |
| 16 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 34,114 | 50.18 USD | |
| 16 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 15,886 | 50.49 USD | |
| 17 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 22,750 | 39.40 USD | |
| 17 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 12,250 | 36.75 USD | |
| 17 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15,000 | 38.60 USD | |
| 17 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 27,710 | 49.95 USD | |
| 17 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 22,290 | 50.73 USD | |
| 18 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 7,250 | 39.40 USD | |
| 18 Mar 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 6,838 | 49.55 USD | |
| 18 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 7,250 | 0.00 USD | deriv |
| 16 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 22,750 | 0.00 USD | deriv |
| 16 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 4,250 | 0.00 USD | deriv |
| 16 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 18,000 | 0.00 USD | deriv |
| 16 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 5,000 | 0.00 USD | deriv |
| 17 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 22,750 | 0.00 USD | deriv |
| 17 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 12,250 | 0.00 USD | deriv |
| 17 Mar 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 25 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1,250 | 0.00 USD | |
| 25 Feb 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 650 | 50.69 USD | |
| 25 Feb 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 1,250 | 0.00 USD | deriv |